🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Apathy is a neurocognitive syndrome characterized by reduced goal-directed ...
Status
Recruiting
Location
Bordeaux University Hospital
Start Date
2021-04-13
Trial ID
NCT03998852
This study looks at the role of the Nociceptin/Orphanin FQ receptor system ...
Status
Recruiting
Location
McLean Hospital
Start Date
2021-12-29
Trial ID
NCT05630963
Treatments Being Tested
The aim of this study is to investigate the feasibility of sentinel node bi...
Status
Completed
Location
Karolinska University Hospital
Start Date
2019-12-14
Trial ID
NCT04147780
Treatments Being Tested
The primary objective of this study is to identify a new radioligand for im...
Status
Withdrawn
Location
John Hopkins Hospital
Start Date
2020-01
Trial ID
NCT03939780
Treatments Being Tested
The goal of this study is to use ultra-high-resolution (UHR) PET imaging to...
Status
Recruiting
Location
UZ Leuven
Start Date
2026-02-13
Trial ID
NCT07509125
The goal of this Phase I clinical trial is to evaluate how the imaging drug...
Status
Recruiting
Location
Excel Diagnostics & Nuclear Oncology Center
Start Date
2026-08-15
Trial ID
NCT07733674
Treatments Being Tested
the investigators make the following assumptions: 1) neuroinflammation in M...
Status
Unknown
Location
Hôpital de Psychiatrie
Start Date
2018-12-07
Trial ID
NCT03314155
Treatments Being Tested
The goal of this prospective, single-arm, open-label clinical trial is to e...
Status
Not Yet Recruiting
Location
Huashan Hospital
Start Date
2026-04-01
Trial ID
NCT07469735
A substance called integrin alpha v beta six (αvβ6) is found to be increase...
Status
Completed
Location
Barts Health NHS Trust
Start Date
2016-03-17
Trial ID
NCT04285996
Treatments Being Tested
The primary goal of this project is to study the feasibility of a prototype...
Status
Terminated
Location
Stanford University
Start Date
2022-07-01
Trial ID
NCT04954248
Treatments Being Tested